These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35167146)

  • 1. The effect of SARS-Co-V2 infection on prothrombotic and anticoagulant factors in dialysis patients.
    Riddell A; Chowdary P; Davenport A
    Artif Organs; 2022 Jul; 46(7):1328-1333. PubMed ID: 35167146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers.
    Sudusinghe D; Riddell A; Gandhi T; Chowdary P; Davenport A
    Hemodial Int; 2023 Jan; 27(1):38-44. PubMed ID: 36081392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
    Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors.
    Calderon-Lopez MT; Garcia-Leon N; Gomez-Arevalillo S; Martin-Serrano P; Matilla-Garcia A
    Blood Coagul Fibrinolysis; 2021 Jan; 32(1):44-49. PubMed ID: 33417336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.
    Ghafouri S; Rettig M; Kahlon KS
    Am J Case Rep; 2020 Oct; 21():e926728. PubMed ID: 33122620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.
    Goldenberg NA; Knapp-Clevenger R; Manco-Johnson MJ;
    N Engl J Med; 2004 Sep; 351(11):1081-8. PubMed ID: 15356305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.
    Molino D; De Santo NG; Marotta R; Anastasio P; Mosavat M; De Lucia D
    Semin Nephrol; 2004 Sep; 24(5):495-501. PubMed ID: 15490419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Composite Study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India.
    Bohra GK; Purohit A; Kumar D; Garg MK; Midha NK; Manglia R; Jain K; Didel S; Nag V; Sharma P; Sharma A; Bhatia P; Misra S
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(3):185-195. PubMed ID: 34852756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.
    Fan BE; Ramanathan K; Sum CLL; Christopher D; Chan SSW; Lim GH; Bok CF; Wong SW; Lye DC; Young BE; Lim JY; Lee RM; Lim SP; Tan HT; Ang MK; Lau SL; Kuperan P; Ong KH; Chia YW
    J Thromb Thrombolysis; 2022 Apr; 53(3):646-662. PubMed ID: 34581945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability.
    van de Berg TW; Hulshof AM; Nagy M; van Oerle R; Sels JW; van Bussel B; Ten Cate H; Henskens Y; Spronk HMH;
    Thromb Res; 2021 May; 201():84-89. PubMed ID: 33662799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.
    Chitolie A; Lawrie AS; Mackie IJ; Harrison P; Machin SJ
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):179-86. PubMed ID: 11414631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation.
    Ambühl PM; Wüthrich RP; Korte W; Schmid L; Krapf R
    Nephrol Dial Transplant; 1997 Nov; 12(11):2355-64. PubMed ID: 9394323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement.
    Virtanen L; Salmela B; Leinonen J; Lemponen M; Huhtala J; Joutsi-Korhonen L; Lassila R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):597-603. PubMed ID: 24732174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oral anticoagulation on clotting during hemodialysis.
    Ziai F; Benesch T; Kodras K; Neumann I; Dimopoulos-Xicki L; Haas M
    Kidney Int; 2005 Aug; 68(2):862-6. PubMed ID: 16014067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.